Investors 1
| Date | Name | Website |
| 17.12.2025 | New York A... | newyorkang... |
Mentions in press and media 2
| Date | Title | Description |
| 19.09.2023 | Israel-based CardiaCare announces closure of its Seed Extension | Israel-based medical device company developing a breakthrough wearable technology for detecting, monitoring, and non-invasively treating cardiac arrhythmias using drug-free neuromodulation, CardiaCare announced the closure of its seed exten... |
| 15.12.2022 | CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment | CardiaCare, a clinical stage digital therapeutic company developing the world’s first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced the execution of a strategic licensing agreement with Dr.... |